Theriva Biologics (TOVX) is making noise in the field of immuno-oncology, supported by a promising pipeline. The stock is up 79% in the past few days on the news the company’s lead clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results